UBS Group’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-84,455
| Closed | -$266K | – | 8034 |
|
2020
Q3 | $266K | Buy |
84,455
+2,760
| +3% | +$8.69K | ﹤0.01% | 3821 |
|
2020
Q2 | $238K | Sell |
81,695
-52,250
| -39% | -$152K | ﹤0.01% | 3888 |
|
2020
Q1 | $378K | Sell |
133,945
-23,210
| -15% | -$65.5K | ﹤0.01% | 3438 |
|
2019
Q4 | $510K | Sell |
157,155
-1,186,838
| -88% | -$3.85M | ﹤0.01% | 3879 |
|
2019
Q3 | $2.9M | Buy |
1,343,993
+394,537
| +42% | +$852K | ﹤0.01% | 2310 |
|
2019
Q2 | $2.98M | Buy |
949,456
+117,036
| +14% | +$368K | ﹤0.01% | 2211 |
|
2019
Q1 | $3.1M | Sell |
832,420
-420,346
| -34% | -$1.56M | ﹤0.01% | 2105 |
|
2018
Q4 | $3.63M | Buy |
1,252,766
+324,428
| +35% | +$941K | ﹤0.01% | 1953 |
|
2018
Q3 | $2.44M | Buy |
928,338
+171,437
| +23% | +$451K | ﹤0.01% | 2462 |
|
2018
Q2 | $1.77M | Sell |
756,901
-172,758
| -19% | -$404K | ﹤0.01% | 2629 |
|
2018
Q1 | $2.73M | Buy |
929,659
+186,343
| +25% | +$548K | ﹤0.01% | 2313 |
|
2017
Q4 | $2.04M | Sell |
743,316
-89,480
| -11% | -$245K | ﹤0.01% | 2517 |
|
2017
Q3 | $2.82M | Buy |
832,796
+110,683
| +15% | +$375K | ﹤0.01% | 2205 |
|
2017
Q2 | $1.78M | Sell |
722,113
-47,118
| -6% | -$116K | ﹤0.01% | 2503 |
|
2017
Q1 | $1.75M | Buy |
769,231
+723,977
| +1,600% | +$1.64M | ﹤0.01% | 2440 |
|
2016
Q4 | $96K | Sell |
45,254
-4,656
| -9% | -$9.88K | ﹤0.01% | 4440 |
|
2016
Q3 | $167K | Buy |
49,910
+5,081
| +11% | +$17K | ﹤0.01% | 3852 |
|
2016
Q2 | $140K | Sell |
44,829
-40,387
| -47% | -$126K | ﹤0.01% | 3986 |
|
2016
Q1 | $284K | Buy |
85,216
+34,639
| +68% | +$115K | ﹤0.01% | 3537 |
|
2015
Q4 | $180K | Buy |
50,577
+9,621
| +23% | +$34.2K | ﹤0.01% | 3843 |
|
2015
Q3 | $206K | Sell |
40,956
-48,940
| -54% | -$246K | ﹤0.01% | 3694 |
|
2015
Q2 | $577K | Buy |
89,896
+14,746
| +20% | +$94.6K | ﹤0.01% | 3158 |
|
2015
Q1 | $529K | Sell |
75,150
-23,968
| -24% | -$169K | ﹤0.01% | 3189 |
|
2014
Q4 | $764K | Buy |
+99,118
| New | +$764K | ﹤0.01% | 2894 |
|